CanVas-derived Programs
Oncology and Autoimmune Diseases
PreclinicalActive
Key Facts
About HAON Life Sciences
HAON Life Sciences is a private, preclinical-stage biotech based in Dublin, Ireland, focused on developing next-generation cell and gene therapies for oncology and autoimmune disorders. The company's core asset is its proprietary CanVas cell therapy platform, which is designed to engineer enhanced therapeutic cells. As a pre-revenue entity, HAON is likely funded by venture capital and grants, positioning it to advance its pipeline through early development stages. The company operates in high-growth therapeutic sectors but faces the typical risks of platform validation and clinical translation.
View full company profileTherapeutic Areas
Other Oncology and Autoimmune Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed TPIM™ Programs | Redesign Science | Pre-clinical |